Corpus Intelligence IC Memo — CONEJOS COUNTY HOSPITAL 2026-04-26 14:21 UTC
IC Memo — CONEJOS COUNTY HOSPITAL
Investment Committee Memorandum | CO | 17 beds | Grade C | EBITDA uplift $1.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CONEJOS COUNTY HOSPITAL

CCN 061308 | CONEJOS, CO | 17 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CONEJOS COUNTY HOSPITAL is a 17-bed suburban community hospital in CONEJOS, CO with $14.1M in net patient revenue and a 5.8% operating margin. The hospital serves a payer mix of 42.0% Medicare, 24.1% Medicaid, and 33.9% commercial.

Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.8% to 13.2% (+737bps).

Net Revenue HCRIS$14.1M
Current EBITDA COMPUTED$822K
Operating Margin COMPUTED5.8%
Occupancy HCRIS17.9%
Revenue / Bed COMPUTED$830K
Net-to-Gross HCRIS54.8%
Distress Probability ML63.8%

2. Market Context & Competitive Position

108
CO Hospitals
-3.6%
State Median Margin
40
Comparable Hospitals

CO has 108 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 5.8% places it above the state median. Among 40 size-comparable peers (8-34 beds), the median margin is -5.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-34), prioritizing same-state peers. 40 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CONEJOS COUNTY HOSPITAL (Target)CO17$14.1M5.8%
VALLEY VIEW HOSPITALCO31$285.3M-3.1%
NATIONAL JEWISH HEALTHCO13$150.4M-50.0%
ASPEN VALLEY HOSPITAL DISTRICTCO25$130.1M0.4%
CENTURA ST. ANTHONY SUMMIT HOSCO34$121.5M28.8%
HEART OF THE ROCKIES REG MED CCO25$117.5M5.4%
YAMPA VALLEY MEDICAL CENTERCO34$116.6M-6.9%
GRAND RIVER HOSPITAL DISTRICTCO25$85.2M-30.8%
CENTURA ST. THOMAS MORE HOSPITCO25$83.7M18.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$296K+210bp18mo
Cost to Collect4.5%2.5%$282K+200bp12mo
Denial Rate Reduction12.0%6.5%$280K+198bp12mo
A/R Days Reduction5200.0%3800.0%$172K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$296K
Cost to Collect
$282K
Denial Rate Reduction
$280K
A/R Days Reduction
$172K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.0M
Current EBITDA$822K
+ RCM Uplift+$1.0M
Pro Forma EBITDA$1.9M
Current Margin5.8%
Pro Forma Margin13.2%
WC Released (1x)$541K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.3M$15.8M12.51x65.8%
Base (11x exit)10.0x11.0x$1.3M$17.8M14.09x69.7%
Bull Case9.0x11.0x$1.1M$21.6M19.03x80.2%
Bull (12x exit)9.0x12.0x$1.1M$23.9M21.05x83.9%
Bear Case11.0x10.0x$1.4M$10.2M7.34x49.0%
Bear (11x exit)11.0x11.0x$1.4M$11.7M8.40x53.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (24.1%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
MediumLow occupancyAt 17.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 63.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 40 hospitals with 8-34 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-17.6% / P50=-5.5% / P75=1.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.